On Friday, Shares of Xcel Energy Inc (NYSE:XEL), subtract -0.72% and closed at $40.05 in the last trading session. The last trading range of the stock ranges between $40.00 and $40.53. Xcel Energy Inc., through its auxiliaries, engages mainly in the generation, purchase, transmission, distribution, and sale of electricity in the United States. It operates through Regulated Electric Utility, Regulated Natural Gas Utility, and All Other segments. The company generates electricity through coal, nuclear, natural gas, hydroelectric, solar, biomass, oil and refuse, and wind energy sources. It also purchases, transports, distributes, and sells natural gas. In addition, the company develops and leases natural gas pipelines, and storage and compression facilities; and invests in rental housing projects.
Spectra Energy Corp. (NYSE:SE), dropped -0.23% and closed at $42.55 in the last trading session. The last trading range of the stock ranges between $42.43 and $43.00. The company’s Market capitalization is $29.76 Billion with the total outstanding Shares of 701.10 million. Spectra Energy Corp (SE) and Spectra Energy Partners (SEP) will declare their third quarter 2016 earnings results before the market opens on Wednesday, November 2, 2016, and will hold a joint shareholder and analyst conference call at 8 a.m. CT that same day.
The webcast will be available via the Spectra Energy and Spectra Energy Partners Shareholders pages. The conference call can be accessed by dialing (888) 252-3715 in the U.S. or Canada, or (706) 634-8942 internationally. The conference ID is 70917863 or “Spectra Energy / Spectra Energy Partners Earnings Call.”
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), lost -8.28% and closed at $1.55 in the last trading session. The last trading range of the stock ranges between $1.55 and $1.71. The company’s Market capitalization is $345.81 million with the total outstanding Shares of 243.26 million. During the 52-week trading session the minimum price at which share price traded, registered at $1.30 and reached to max level of $2.68. Arena Pharmaceuticals, Inc. (ARNA) recently declared that Dr. Laurent Peyrin-Biroulet will present etrasimod S1P receptor profile data at the United European Gastroenterology Week (UEGW) Meeting on Tuesday, October 18 at 6:15am ET. The meeting is taking place October 15-19 in Vienna, Austria. The data will also be published in the December issue of United European Gastroenterology Journal, a peer-reviewed medical journal providing coverage of both translational in addition to clinical studies from all fields of gastroenterology.